Kennedy Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
AAM
PCM
PCMI
Kennedy Capital Management's NPTN Position: Q2 2022 in Review
Kennedy Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 150,850 shares — an estimated $2.29M sold.
Kennedy Capital Management first reported a position in NPTN in Q2 2017 and held it in 20 quarters. The position peaked at $15.5M in Q4 2021. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.
- Kennedy Capital Management reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
- Kennedy Capital Management sold 150,850 NEOPHOTONICS CORP shares in Q2 2022, an estimated $2.29M.
- Kennedy Capital Management first reported a position in NEOPHOTONICS CORP in Q2 2017 and held it in 20 quarters.
- Kennedy Capital Management's NEOPHOTONICS CORP position peaked at $15.5M in Q4 2021.
- 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.
Based on Kennedy Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.